(Q40606312)

22 September 2017

title

Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation (English)

1 reference

22 September 2017

1 reference

Silvia Mateo-Lozano

1

1 reference

22 September 2017

Oscar M Tirado

series ordinal

2

1 reference

22 September 2017

Vicente Notario

series ordinal

3

1 reference

22 September 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

22 September 2017

1 reference

22 September 2017

volume

22

1 reference

22 September 2017

issue

58

1 reference

22 September 2017

page(s)

9282-9287

1 reference

Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Biology of EWS/ETS fusions in Ewing's family tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Variability in gene expression patterns of Ewing tumor cell lines differing in EWS-FLI1 fusion type

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Advances in systemic therapy of small cell cancer of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Association of EWS-FLI1 type 1 fusion with lower proliferative rate in Ewing's sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Loss of p16 pathways stabilizes EWS/FLI1 expression and complements EWS/FLI1 mediated transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Regulation of translation initiation by FRAP/mTOR

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Global and specific translational control by rapamycin in T cells uncovered by microarrays and proteomics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

The rapamycin-sensitive signal transduction pathway as a target for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Rapamycin is an effective inhibitor of human renal cancer metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Identification of p21WAF1/CIP1 as a direct target of EWS-Fli1 oncogenic fusion protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Treatment of Ewing sarcoma family of tumors: current status and outlook for the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

FRAP-p70s6K signaling is required for pancreatic cancer cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Beta-platelet-derived growth factor receptor mediates motility and growth of Ewing's sarcoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

Rapamycin induces heme oxygenase-1 in human pulmonary vascular cells: implications in the antiproliferative response to rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

PDGF-C is an EWS/FLI induced transforming growth factor in Ewing family tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

p70s6k function is essential for G1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

A link between basic fibroblast growth factor (bFGF) and EWS/FLI-1 in Ewing's sarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

7 January 2021

Repression of the gene encoding the TGF-beta type II receptor is a major target of the EWS-FLI1 oncoprotein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

7 January 2021

Molecular genetics of chromosome translocations involving EWS and related family members

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

7 January 2021

Combinatorial generation of variable fusion proteins in the Ewing family of tumours.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207081

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207081

1 reference

Dimensions Publication ID

22 September 2017

1023496894

0 references

1 reference